Leash Bio

BiotechnologySeedSalt Lake City, USleash.bio

Latest round

Seed

Last raised

Apr 2024

Total raised

$9.3M

Investors

5

About Leash Bio

Founded in 2021 and based in Utah, US, Leash Bio operates as a biotechnology research firm that is building datasets of medicinal chemistry compounds using machine learning. Ian Quigley (CEO) and Andrew Blevins (CTO) are the co-founders of the company. Global Investment, and MFV Partners.  The company offers a proprietary platform that is built upon a dataset compiled through screening of compounds against proteins, resulting in data points. This dataset serves as the foundation for training machine learning models, enabling them to identify drug candidates with accuracy. The firm’s platform also encompasses a cyclical engine that continuously iterates through data collection, machine learning, and refinement processes. Leash Bio’s software further enhances its capabilities, facilitating the design and optimization of chemical matter.

Who invested in Leash Bio

5 investors across 1 round

See all investors in Leash Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Apr 5, 2024

    Amount

    $9.3M

    Investors

    Locked

Questions about Leash Bio

Who invested in Leash Bio?

Leash Bio has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Leash Bio raised?

Leash Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Leash Bio last raise money?

Leash Bio's most recent round on record is a Seed, in Apr 2024.

What does Leash Bio do?

Founded in 2021 and based in Utah, US, Leash Bio operates as a biotechnology research firm that is building datasets of medicinal chemistry compounds using machine learning.

Where is Leash Bio headquartered?

Leash Bio is headquartered in Salt Lake City, US.

Which VCs invest in companies like Leash Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Leash Bio's stage. Their profiles are linked below.

Raising like Leash Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.